GMF Capital

Venture Capital

Private investment firm focused on life sciences and healthcare companies.

Profile

Headquarters
San Francisco, US
Investments
2
Companies
1

Capital

Total Deployed
$127M
Lead Rounds
0

Portfolio

1 company
Pardes Biosciences $127M
Acquired Carlsbad, US

Clinical-stage biopharmaceutical company that developed novel oral antiviral therapeutics targeting COVID-19. Went public via SPAC merger in 2021 before being acquired by MediPacific (a Foresite Capital affiliate) in 2023 after its lead candidate failed Phase 2 trials.

Investment data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.